baber/WOPTO huggingface dataset:
Patent FI-950406-A0 (FI)
Inventor: ARAL HALIL
IPC: C22B60/02
Filed: 1995-01-30
Abstract: PCT No. PCT/AU93/00381 Sec. 371 Date Apr. 6, 1995 Sec. 102(e) Date Apr. 6, 1995 PCT Filed Jul. 28, 1993 PCT Pub. No. WO94/03160 PCT Pub. Date Feb. 17, 1994A process for facilitating the removal of impurities e.g. radionuclides, such as uranium and thorium, and/or one or more of their radionuclide daughters, from titaniferous material includes contacting the titaniferous material with one or more reagents at an elevated temperature selected to enhance the accessibility of at least one of the radionuclide daughters in the titaniferous material. The reagent(s) may be a glass forming reagent and is selected to form a phase at the elevated temperature which disperses onto the surfaces of the titaniferous material and incorporates the radionuclides and one or more radionuclide daughters. The titaniferous material may be, e.g., ilmenite, reduced ilmenite, altered ilmenite or synthetic rutile.
Patent FI-950916-A0 (FI)
Inventor: POSTI HARRI
IPC: H04B7/26
Filed: 1995-02-28
Abstract: PCT No. PCT/FI96/00112 Sec. 371 Date Dec. 22, 1997 Sec. 102(e) Date Dec. 22, 1997 PCT Filed Feb. 26, 1996 PCT Pub. No. WO96/27269 PCT Pub. Date Sep. 6, 1996The present invention relates to a base station of a radio system. The base station has means for establishing a telecommunication connection to radio units in a coverage area of the base station. In order to utilize a capacity of the base station efficiently, the base station comprises a central processing unit with at least one baseband frame unit for supplying baseband signals via switching means, alternatively, to one of at least two radio channel units, and at least two radio set units arranged separately from one another of which at least one of the radio set units is arranged at a distance from the central processing unit. The radio set units are arranged into different radio set units for transferring baseband signals to be transmitted from the frame unit to a radio channel and for forwarding radio frequency signals via an antenna means of the radio set unit.
Patent FI-953256-A0 (FI)
Inventor: KAAN ELBERT
IPC: A61P3/10
Filed: 1995-06-30
Abstract: The use of 4-chloro-5-((4,5-dihydro-1H-imidazol-2-yl)- amino)-6-methoxypyrimidine of formula (I) or its acid addn. salts is claimed for the prepn. of pharmaceutical compsns. for the treatment of hyperglycaemia. Also claimed in the prepn. of such as compsn. by converting an antihyperglycaemically active amt. of (I) or its salt into a suitable dosage form, in combination with conventional auxiliaries.
Patent FI-954965-A0 (FI)
Inventor: WAETJEN FRANK
IPC: A61P43/00
Filed: 1995-10-18
Abstract: The present patent application discloses compounds having formula (I) or a pharmaceutically acceptable salt thereof wherein R<1> is hydrogen, alkyl or benzyl; X is O or NOR<2>, wherein R<2> is hydrogen, alkyl or benzyl; Y is N-R<4> wherein R<4> is hydrogen, OH or alkyl; n is 0 or 1; R<6> is phenyl, naphthyl, thienyl, pyridyl, all of which may be substituted one or more times with substituents selected from the group consisting of halogen; CF3, NO2, amino, alkyl, alkoxy and phenyl; A is a ring of five to seven atoms fused with the benzo ring at the positions marked a and b. The compounds are useful in the treatment of cerebrovascular disorders for example.
Patent AP-9400644-A0 (AP)
Title: Substituted pyrazolines.
Inventor: DR VAN ALMSICK ANDREAS
IPC: A01N47/38
Filed: 1994-05-26
Abstract: Substituted pyrazoline derivatives of general formula 1 in which r1,r2 and r4, which may be the same of different, are hydrogen or are phenyl, cycloalkyl, cycloalkenyl, alkyl, alkoxycarbonyl, alkylcarbonyl or alkenyl, each of which is optionally substituted, or r1 and r2 together form an optionally benzo fused alkylene group, r3 and r5 which may be the same or different, are hydrogen or optionally substituted alkyl, r6, r7 and r8, which may be the same or different are hydrogen, nitro or cyano or are phenyl, cycloaalkyl, cycloalkenyl, alkyl,alkoxy, alkylthio, alkoxycarbonyl, alkylxarbonyl or alkenyl, each of which is optionally substituted, or r6 and r7 together the c-c double bond attached to the nitrogen form an optionally substituted cycloalkenyl ring, have insecticidal acaricidal activity.
Patent AP-9901720-A0 (AP)
Title: Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitors.
Inventor: SMITH STEPHEN ALISTAIR
IPC: A61K31/4439
Filed: 1998-06-15
Abstract: A method for the treatment of diabetes mellitus and conditons associated with diabetes mellitus in a mammal, which method comprises administering an effective non-toxic and pharmaceutically acceptable amount of an insulin sensitiser and an alpha-glucosidase inhibitor antihyperglycaemic agent, to a mammal in need thereof.
Patent IL-78270-A0 (IL)
Title: Dedicated ribosomes and their use
IPC: C12N15/70
Filed: 1986-03-25
Abstract: A method is described that dedicates specialized ribosomes to the synthesis of desired proteins. DNA which encodes rRNA having a mutant anti-Shine-Dalgarno sequence is used to transform a host cell in combination with DNA encoding messenger RNA for the desired protein having a complementary mutant Shine-Dalgarno sequence. Since the mutant sequences are selected so as to be substantially unrecognized by either endogenous messenger RNA or ribosomes, respectively, the synthesis of protein proceeds in a dedicated system without interference from other host cell protein synthetic machinery.
Patent IL-81337-A0 (IL)
Title: Heptanoyl-glu-asp-ala-amino acid immunostimulants
IPC: C07K5/08
Filed: 1987-01-21
Abstract: Compounds of the formula 
<CHEM>
 wherein R<1> is hydrogen or benzyl;
 R<2> is hydrogen or methyl; 
<CHEM>
 wherein Z is hydrogen or carbobenzyloxy; and Y is hydrogen or t-butoxycarbonyl, and pharmaceutically acceptable salts of those compounds wherein at least one of Y, Z, R<1> or R<2> is hydrogen. 
<??>These compounds are useful as anti-infective agents and immunomodulators for stimulation of host defences in patients with an increased risk of bacterial infections.
Patent IL-86289-A0 (IL)
Title: Teicoplanin derivatives
IPC: A61P31/04
Filed: 1988-05-05
Abstract: The present invention is directed to new antibiotic substances which are 34-de-(acetylaminoglucopyranosyl)-34-deoxy teicoplanin derivatives (I) possessing antimicrobial activity in particular against gram positive bacteria. <CHEM>  wherein  A    represents hydrogen or OA represents N[(C10-C11) aliphatic acyl]-beta-D-2-deoxy-2-amino-glucopyranosyl,  M represents hydrogen or OM represents alpha-D-manno-pyranosyl, with the proviso that when M represents hydrogen also A must represent hydrogen, and the addition salts thereof. w
Patent IL-88124-A0 (IL)
Title: Pharmaceuticals,phosphorus-containing-2-isoxazolines and isoxazoles contained therein and processes for the preparation of these compounds
IPC: C07F9/547
Filed: 1988-10-23
Abstract: The medicine contains or consists of at least one compound of the formula I and/or optionally one of its physiologically tolerated salts, where the compounds of the formula I can optionally be in the form of pure stereoisomers or mixtures thereof; formula I is: 
<IMAGE>
 in which R<1> = organic radical or halogen
 A = C,C single or C,C double bond,
 n = 0, 1 or 2 and
 X and Y = alkyl radical or
 = -OR<2> or -NR<2>R<3> with R<2>, R<3> = H or optionally substituted aliphatic radical. 
<??>The medicines are suitable for the prophylaxis and/or treatment of disorders of the immune system.
Patent IL-93679-A0 (IL)
Title: Plaster having graduated release for the administration of active substances to the skin,and a process for its production
IPC: A61L15/44
Filed: 1990-03-08
Abstract: Transdermal patches for controlled release of a drug comprise at least one drug reservoir in contg. with a drug-contg. release-controlling matrix, with a backing layer on the skin-distal side of the matrix and an adhesive layer on the skin-proximal side. The size and posn. of each drug reservoir are such that in at least one direction, the distance between the reservoir and the drug delivery surface of the matrix is greater than the diffusion path length of at least one drug from its reservoir into the matrix during the period of application.
Patent AU-PP855099-A0 (AU)
Title: Gas delivery connection assembly
IPC: A61M16/20
Filed: 1999-02-09
Abstract: The present invention relates to a patient gas delivery apparatus including: 
a mask adapted for communication with a patient's airways; 
a gas flow generator and gas delivery conduit means, further including an assembly connected in series between the conduit and the mask; 
said assembly being formed in at least two parts connected by interengaging connecting means, said assembly further including means for connection to the mask, wherein connection of the assembly to the mask prevents incorrect assembly or incorrect alignment of said parts.
Patent FI-20002215-A0 (FI)
Inventor: KAUPPINEN ESKO
IPC: A61P5/00
Filed: 2000-10-06
Abstract: Crystalline spherical inhalation particles incorporating a combination of two or more different active ingredients and a process for the preparation thereof. The particles have a narrow particle size distribution, rough surfaces and improved stability. The inhalation particles of the invention are particularly useful in the administration of a combination medicament, e.g. a combination of an anti-inflammatory agent and a bronchodilator, by inhalation in the treatment of asthma and other respiratory disorders.
Patent FI-20020800-A0 (FI)
Inventor: OKHOTNIKOV OLEG
IPC: H01S3/106
Filed: 2002-04-26
Abstract: The invention relates to an optically pumped multilayered modulator having surface-normal geometry. The multilayer structure comprises an absorber section through which an optical signal ( 401 ) to be modulated is coupled from an input ( 401 ) to an output ( 400 ). The multilayer structure further comprises control means for supplying a control signal for controlling the transmission characteristics of the absorber section. The control signal is generated by an in-plane waveguide-type laser integrated monolithically with the saturable absorption region. The in-plane control laser includes waveguide regions ( 405 ) and multiple-quantum-well layers ( 409 ) used as a gain medium. The laser beam is adapted to travel through the absorber section in order to modulate the transmission characteristics of the absorber section.
Patent FI-20050460-A0 (FI)
IPC: F27D11/10
Filed: 2005-04-29
Abstract: The invention is an electric insulation system for a steel-structured lid of an electric arc furnace, where the electrode lead-throughs are provided with electric insulation for preventing breakdowns, and the lid is sealed from the furnace vessel by means of a sand seal. The lid is divided by steel-structured panels to at least six mutually electrically insulated segments, three of which form the lid center part, so that each center part segment outlines one lead-through of an electrode, and at least three of which form the outer perimeter of the lid.
Patent FI-20065082-A0 (FI)
IPC: C23C/
Filed: 2006-02-02
Abstract: In the method, metal is protected using an Atomic Layer Deposition method for producing a thin film coating on the surface of metal by depositing successive molecule layers of the coating material. For example aluminium oxide (Al 2 O 3 ) or zirconium oxide may be used as the coating material.
Patent FI-20075253-A0 (FI)
Inventor: MIELONEN EERO
IPC: B65G/
Filed: 2007-04-13
Abstract: A side guiding piece for guiding the chain of a lamellar chain conveyor or other wheel-supported chain conveyor laterally comprises means (7, 9, 12, 13, 20) for attaching it to the chain of the lamellar chain conveyor. A bracket (5) extending to behind at least one wheel (14) of the conveyor chain and support means (12, 13) supported by the axle structure (14) of at least one wheel are arranged into the lateral guide piece. One lateral guide piece comprises locking means (7, 9, 12, 13, 20) supported by at least two consecutive axle structures (14).
Patent IL-103270-A0 (IL)
Title: Sparfloxacin solution and its preparation
IPC: A61K9/08
Filed: 1992-09-24
Abstract: Pharmaceutical composition consisting of a stable aqueous solution of the sparfloxacin of formula: <IMAGE>  containing     - sparfloxacin, - one or more monocarboxylic polyhydroxyacids or lactone derivatives thereof, at least in a stoichiometric quantity relative to the sparfloxacin, - if necessary, an excess of monocarboxylic polyhydroxyacid or of another pharmaceutically acceptable acid intended to ensure a pH for complete solubilisation of the salt thus formed, less than or equal to 5, - optionally, an isotonising agent and/or other pharmaceutically acceptable adjuvants.
Patent IL-103699-A0 (IL)
Title: Shaped articles which contain active compounds and are based on elastomeric copolyesters,which can be processed as thermoplastics,their products and their use for control of pests
IPC: C08L67/02
Filed: 1992-11-10
Abstract: The present invention relates to mouldings containing active ingredients, which are characterised in that they contain, as support, thermoplastic elastomers based on copolyesters, optionally with conventional additives, to a process for their production, and to their use for the control of pests on animals.
Patent IL-105410-A0 (IL)
Title: Triaryl phosphate ester composition and process for its preparation
IPC: C07F9/12
Filed: 1993-04-15
Abstract: The invention is a novel composition of alkylated phenyl phosphate esters comprising by weight 1% to 20% trialkylphenyl phosphate, 10% to 50% dialkylphenyl monophenyl phosphate, 15% to 60% monoalkylphenyl diphenyl phosphate and less than 2% triphenyl phosphate and a process for preparing the composition comprising passing the composition at least once through a thin film evaporator at a temperature of about 200<o>C to about 250<o>C at a pressure sufficiently less than 5 kPa to evaporate about 5% to about 30% of the composition.
Patent IL-117921-A0 (IL)
Title: Polycyclic amine compounds and their enantiomers their preparation and pharmaceutical compositions containing them
IPC: A61P9/00
Filed: 1996-04-16
Abstract: The invention relates to compounds of formula (I): <IMAGE>  in which     - Y represents - either a Cy-N or Cy-CH2-N group in which Cy represents an optionally substituted phenyl;   - or a group <IMAGE> in which     .Ar represents an optionally substituted phenyl;   .x is zero or one; .X represents a hydrogen, a hydroxyl, an alkoxy; an acyloxy; a carboxy; a carbalkoxy; a cyano; a -N(X1)2 group in which the groups X1 independently represent hydrogen, an alkyl, a hydroxyalkyl, an acyl, or alternatively -(X1)2 constitutes, with the nitrogen atom to which it is attached, a heterocycle; an -S-X2 group in which X2 represents hydrogen or an alkyl group; or alternatively X forms, with the carbon atom to which it is attached and with the adjacent carbon atom in the heterocycle, a double bond;     - m is 2 or 3; - Ar' represents an optionally substituted phenyl or a phenyl substituted one or more times with a thienyl; a benzothienyl; a naphthyl or an indolyl;   - n is 0, 1, 2 or 3; - p is 1 or 2 and when p = 2, then n = 1 and Q represents two hydrogen atoms;   - Q represents oxygen or two hydrogen atoms;   - T represents a group chosen from <IMAGE>   - q is 0, 1, 2 or 3; - Z represents an optionally substituted phenyl; an optionally substituted naphthyl; a pyridyl; a thienyl; an indolyl; a quinolyl; a benzothienyl; an imidazolyl; or alternatively, when T is -C=O, -(CH2)q-Z may also represent a benzyl group substituted on the -CH- and optionally substituted on the aromatic ring; an optionally substituted mono-, di- or tricyclic aromatic or heteroaromatic group;   or one of their possible salts with inorganic or organic acids, or when <IMAGE> one of their quaternary ammonium salts with the nitrogen (b) of piperidine or N-oxide derivatives with the same nitrogen atom. The invention also relates to the process for preparing them and to their enantiomers. Application: antagonists of neurokinin receptors.
Patent IL-121836-A0 (IL)
Title: 5-(2,5-disubstituted phenyl)-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-ones for use as medicaments for the treatment of impotence
IPC: A61K31/505
Filed: 1997-09-25
Abstract: The use of a compound of formula (I) wherein R1 is H; C1-C3 alkyl; C1-C3 perfluomalkyl; or C3-C5 cycloalkyl; R2 is H; optionally substituted C1-C6 alkyl; C1-C3 pefluoroalkyl; or C3-C6 cycloalkyl; R3 is optionally substituted C1-C6 alkyl; C1-C6 perfluoroalkyl; C3-C5 cycloalkyl; C3-C6 alkenyl; or C3-C6 alkynyl; R4 is optionally substituted C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkanoyl, (hydroxy)C2-C4 alkyl or (C2-C3 alkoxy)C1-C2 alkyl; CONR5R6; CO2R7; halo; NR5R6; NHSO2NR5R6; NHSO2R8; SO2NR9R10; or phenyl, pyridyl, pyrimidinyl, imidazolyl, oxazolyl, thiazolyl, thienyl or triazolyl any of which is optionally substituted with methyl; R5 and R6 are each independently H or C1-C4 alkyl, or together with the nitrogen atom to which they are attached form an optionally substituted pyrrolidinyl, piperidino, morpholino, 4-N(R11)-piperazinyl or imidazolyl group; R7 is H or C1-C4 alkyl; R8 is optionally substituted C1-C3 alkyl; R9 and R10 together with the nitrogen atom to which they are attached form an optionally su
Patent IL-124834-A0 (IL)
Title: Method for preparation of type ii collagen
IPC: A61K38/00
Filed: 1997-01-03
Abstract: An method is disclosed for removing Type I collagen-containing tissue adjoining Type II collagen-containing animal tissue comprising treatment of unprocessed Type II collagen-containing tissue in an acidic solution in the presence of an acid proteinase and subjecting the mixture to moderate agitation for a period of time sufficient to cause digestion or separation of the Type I collagen-containing tissue from the Type II collagen-containing tissue. Also disclosed are methods for removing proteoglycans from Type II collagen-containing tissue.
Patent IL-135221-A0 (IL)
Title: Natural humanized antibody and methods for the preparation thereof
IPC: C12N1/19
Filed: 1998-10-02
Abstract: A reshaped human anti-HM1.24 antibody comprising:   (A) L chains each comprising (1) a constant region of a human L chain, and (2) FRs of a human L chain, and CDRS of L chain of mouse anti-HM1.24 monoclonal antibody; and (B) H chains each comprising (2) a constant region of a human H chain, and (2) FRs of a human H chain, and CDRs of H chain of mouse anti-HM1.24 monoclonal antibody. Since the majority of the reshaped human antibody is derived from human antibody and the CDR has a low antigenicity, the reshaped human antibody of the present invention has low antigenicity and therefore is very promising in medical and therapeutic applications.
Patent IL-142156-A0 (IL)
Title: Method, equipment and system for signaling in a network including ethernet
IPC: H04L29/08
Filed: 2001-03-21
Abstract: There is proposed a method of providing a signaling channel for performing one or more signaling functions at the level of Ethernet. The telecommunication of interest is organized by information packets forming an information flow, and the method comprises utilizing a combined flow composed from the information flow and one or more service flows formed from service packets being compatible with the information packets. The service packets belonging to a particular service flow carry indication of a corresponding one of the signaling functions to be performed, while the one or more service flows form the signaling channel at the level of Ethernet.
Patent IL-144338-A0 (IL)
Title: Nucleoside and oligonucleotide analogues and pharmaceutical compositions containing the same
IPC: C07H19/067
Filed: 2000-02-10
Abstract: The object of the present invention is to provide novel oligonucleotide analogues, which exhibit antisense or antigene activity having excellent stability, or exhibit excellent activity as a detection agent (probe) for a specific gene or as a primer for starting amplification, and to novel nucleoside analogues which are intermediates for their production. ÄSolutionÜ   A compound of the formula (1): <CHEM> Äwherein R<1> and R<2> are the same or different and represent a hydrogen atom, a hydroxyl protecting group, a phosphoric acid group, or -P(R<3>)R<4> Äwherein R<3> and R<4> are the same or different and represent a hydroxyl group, an amino group, an alkoxy group having from 1 to 4 carbon atoms, a cyanoalkoxy group having from 1 to 5 carbon atoms or an amino group substituted by an alkyl group having from 1 to 4 carbon atomsÜ; A represents an alkylene group having from 1 to 4 carbon atoms; and B represents a purin-9-yl group, a 2-oxo-pyrimidin-1-yl group or a substituted purin-9-yl group or a substituted 2-oxo-pyrimidin-1-yl group having a substituent selected from the following  alpha groupÜ;  or the salt thereof; ( alpha  group> a hydroxyl group which may be protected, an alkoxy group having from 1 to 4 carbon atoms, a mercapto group which may be protected, an alkylthio group having from 1 to 4 carbon atoms, an alkoxy group having from 1 to 4 carbon atoms, an amino group which may be protected, a mono- or di-alkylamino group which may be substituted by an alkyl group having from 1 to 4 carbon atoms, an alkyl group having from 1 to 4 carbon atoms and a halogen atom. A compound of the formula (I), and the pharmacologically acceptable salts or derivatives thereof.
Patent IL-157208-A0 (IL)
Title: 4-fluoro-n-indan-2-yl benzamide and its use as pharmaceutical
IPC: A61P9/00
Filed: 2002-02-12
Abstract: A method of stimulating the expression of endothelial NO-synthase in a mammal, which method comprises administering a physiologically active amount of 4-fluoro-N-indan- 2-yl benzamide according to the formula (I)
Patent IL-166182-A0 (IL)
Title: Simmondsin for use as an angiogenesis inhibitor
IPC: A61K36/185
Filed: 2005-01-06
Abstract: Methods of inhibiting angiogenesis in humans and animals by administering an effective amount of a secondary plant metabolite from jojoba, having the general formula I shown below, are disclosed. Preferred compounds having general formula I include 4-desmethylsimmondsin, 5-desmethylsimmondsin, 4,5-didesmethylsimmondsin, 4,5-dimethylsimmondsin, 4-desmethylsimmondsin-2'-ferulate, 5-desmethylsimmondsin-2'-ferulate, 4,5-didesmethylsimmondsin-2'-ferulate and 4,5-dimethylsimmondsin-2'-ferulate. Such compounds can be synthesized chemically according to well known techniques or can be isolated from refined and de-oiled jojoba flour by conventional extraction techniques using polar solvents such as a ketone or a low boiling point alcohol. Pharmaceutical compositions for inhibiting angiogenesis or for treating angiogenesis-related diseases in humans or animals are disclosed.
Patent IL-207056-A0 (IL)
Title: A sub calibre projectile of the fin-stabilised type incorporating a sabot and a penetrator
Filed: 2010-07-18
Abstract: The device has a front part (F) and a rear part (R) in which axial clearances between teeth (9) of a sub-calibrated bar (3) and grooves (8) forming housings in a sabot (2) are variable. The axial clearance realized at the level of each of the front and rear parts is increased between a median zone (M) of the sabot and a front end or rear end of the sabot. The median zone is longitudinally placed at the level of a thrust plate of the sabot and has a length less than or equal to 30 percent of total length of an interface between the sabot and the bar.
Patent IL-226555-A0 (IL)
Title: Methods for treating bone cancer pain by administering a nerve growth factor antagonist
IPC: C07K16/00
Filed: 2013-05-23
Abstract: The invention features methods and compositions for preventing or treating bone cancer pain including cancer pain associated with bone metastasis by administering an antagonist of nerve growth factor (NGF). The NGF antagonist may be an anti-NGF (such as an anti-hNGF) antibody that is capable of binding hNGF.